Inhibition of protein synthesis in reticulocytes by antibiotics. II. The site of action of cycloheximide, streptovitacin A and pactamycin.
Luciano Felicetti, Bruno Maria Colombo, Corrado Baglioni
Abstract
Luciano Felicetti, Bruno Maria Colombo, Corrado Baglioni
Abstract
The inhibition of protein synthesis by cycloheximide, streptovitacin A and pactamycin has been studied. The inhibition by pactamycin has been located in the ribosomal fraction. The ribosomes of reticulocytes incubated with pactamycin are not stimulated by polyuridylic acid in a cell-free system. Thus pactamycin appears to alter a ribosomal site which is involved in the interaction between messenger RNA, transfer RNA, and ribosome, and which is essential to protein synthesis. Cycloheximide and streptovitacin A specifically inhibit the formation of the peptide bond catalyzed by a 100 000 × g supernatant factor. This has been shown by experiments with puromycin which indicate that cycloheximide and streptovitacin A inhibit the release, caused by puromycin, of incomplete peptide chains from polysomes. Since the release of peptide chains by puromycin requires the formation of a peptide bond, the supernatant factor inhibited by cycloheximide and streptovitacin A has been tentatively identified with the enzyme peptide synthetase.
OpenAlex reports 125 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The inhibition of protein synthesis by cycloheximide, streptovitacin A and pactamycin has been studied. The inhibition by pactamycin has been located in the ribosomal fraction. The ribosomes of reticulocytes incubated with pactamycin are not stimulated by polyuridylic acid in a cell-free system. Thus pactamycin appears to alter a ribosomal site which is involved in the interaction between messenger RNA, transfer RNA, and ribosome, and which is essential to protein synthesis. Cycloheximide and streptovitacin A specifically inhibit the formation of the peptide bond catalyzed by a 100 000 × g supernatant factor. This has been shown by experiments with puromycin which indicate that cycloheximide and streptovitacin A inhibit the release, caused by puromycin, of incomplete peptide chains from polysomes. Since the release of peptide chains by puromycin requires the formation of a peptide bond, the supernatant factor inhibited by cycloheximide and streptovitacin A has been tentatively identified with the enzyme peptide synthetase.
Key concepts: Cycloheximide, Antibiotics, Protein biosynthesis, Site of action, Chemistry, Biochemistry, Biology, Endocrinology